Cargando…
Alemtuzumab-Induced Autoimmune Thyroid Dysfunction
Alemtuzumab, a humanized monoclonal antibody used as a disease-modifying treatment in relapsing-remitting multiple sclerosis (RRMS), frequently causes autoimmunity as its principal adverse effect. We describe a typical case of a young man treated with two courses of alemtuzumab presenting 18 months...
Autores principales: | Ragavan, Sharanniyan, Elhelw, Omar, Majeed, Waseem, Kyriacou, Angelos, Syed, Akheel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971069/ https://www.ncbi.nlm.nih.gov/pubmed/35371892 http://dx.doi.org/10.7759/cureus.22751 |
Ejemplares similares
-
Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report
por: AlShehri, Sara, et al.
Publicado: (2022) -
Autoimmune Thyroiditis with Hypothyroidism Induced by Sugar Substitutes
por: Sachmechi, Issac, et al.
Publicado: (2018) -
Coexistence of Autoimmune Thyroiditis and Juvenile Idiopathic Arthritis
por: Sapountzi, Evdoxia, et al.
Publicado: (2023) -
Association of Autoimmune Hashimoto's Thyroiditis with Systemic Lupus Erythematosis
por: Kammari, Chetan B, et al.
Publicado: (2020) -
Thyroid Storm-Induced Acute Liver Dysfunction and Disseminated Intravascular Coagulation
por: Kim, Yungmin, et al.
Publicado: (2021)